ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.978,03
-0,13%
S&P 500
5.996,66
1,00%
Dow Jones
43.487,83
0,00%
Euro vs US Dollar
1,03543
-0,64%
Bitcoin
104.418,83
2,34%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Inovio Pharmaceuticals Inc New (INO) Börsenkurse

Inovio Pharmaceuticals Inc New

Inovio Pharmaceuticals Inc New (INO)

Inseego Corp
2,08
0,17
(8,90%)
Geschlossen 18 Januar 10:00PM
Verzögert um 15 Minuten
2,08
0,00
( 0,00% )
Vor Marktöffnung: 1:41PM
Verzögert um 15 Minuten

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
2,08
Gebot
2,10
Fragen
2,14
Volumen
3.416
0,00 Tagesbereich 0,00
1,74 52-Wochen-Bereich 14,748
Marktkapitalisierung
54,288M
Handelsende
2,08
Handelsbeginn
-
Letzte Trade
80
@
2.08
Letzter Handelszeitpunkt
13:29:41
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
966.760
Ausgegebene Aktien
26.099.991
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,40
Gewinn pro Aktie (EPS)
-5,18
Erlöse
832k
Nettogewinn
-135,12M

Über Inovio Pharmaceuticals Inc New

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and... Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies. Mehr anzeigen

Sektor
Surgical,med Instr,apparatus
Branche
Surgical,med Instr,apparatus
Website
www.inovio.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Inovio Pharmaceuticals Inc New is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker INO. The last closing price for Inovio Pharmaceuticals was US$2,08. Over the last year, Inovio Pharmaceuticals shares have traded in a share price range of US$ 1,74 to US$ 14,748.

Inovio Pharmaceuticals currently has 26.099.991 shares in issue. The market capitalisation of Inovio Pharmaceuticals is US$54,29 million. Inovio Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.40.

INO Neueste Nachrichten

Weitere Nachrichten

INOVIO Highlights Anticipated 2025 Milestones and 2024 Key Accomplishments

INOVIO Highlights Anticipated 2025 Milestones and 2024 Key Accomplishments PR Newswire PLYMOUTH MEETING, Pa., Jan. 9, 2025 PLYMOUTH MEETING, Pa., Jan. 9, 2025 /PRNewswire/ -- INOVIO (NASDAQ:...

09 Januar 2025
PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities

19 Dezember 2024
Edgar (US Regulatory)

Form 8-K - Current report

16 Dezember 2024
Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]

13 Dezember 2024
Edgar (US Regulatory)

INOVIO Announces Pricing of $30 Million Public Offering

INOVIO Announces Pricing of $30 Million Public Offering PR Newswire PLYMOUTH MEETING, Pa., Dec. 13, 2024 PLYMOUTH MEETING, Pa., Dec. 13, 2024 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq:...

13 Dezember 2024
PR Newswire (US)

Form 424B5 - Prospectus [Rule 424(b)(5)]

12 Dezember 2024
Edgar (US Regulatory)

INOVIO Announces Proposed Public Offering

INOVIO Announces Proposed Public Offering PR Newswire PLYMOUTH MEETING, Pa., Dec. 12, 2024 PLYMOUTH MEETING, Pa., Dec. 12, 2024 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a...

12 Dezember 2024
PR Newswire (US)

New Retrospective Data Shows Half of RRP Patients Treated with INO-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial

New Retrospective Data Shows Half of RRP Patients Treated with INO-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial PR Newswire PLYMOUTH MEETING...

03 Dezember 2024
PR Newswire (US)

INOVIO Reports Inducement Grant Under Inducement Plan

INOVIO Reports Inducement Grant Under Inducement Plan PR Newswire PLYMOUTH MEETING, Pa., Nov. 29, 2024 PLYMOUTH MEETING, Pa., Nov. 29, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology...

29 November 2024
PR Newswire (US)

INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights

INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights PR Newswire PLYMOUTH MEETING, Pa., Nov. 14, 2024 New immunology data for INO-3107 supporting proposed mechanism...

14 November 2024
PR Newswire (US)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.178.900523560211.912.121.82157065721.94277621CS
40.2815.55555555561.82.391.7512479672.0028344CS
12-3.57-63.1858407085.655.771.749667602.69249735CS
26-8.05-79.466929911210.1312.331.745964123.93714569CS
52-6.08-74.50980392168.1614.7481.745582296.37715626CS
156-47.72-95.823293172749.852.05121.74388490917.78156553CS
260-40.16-95.075757575842.244261.749155250122.25674312CS

INO - Frequently Asked Questions (FAQ)

What is the current Inovio Pharmaceuticals share price?
The current share price of Inovio Pharmaceuticals is US$ 2,08
How many Inovio Pharmaceuticals shares are in issue?
Inovio Pharmaceuticals has 26.099.991 shares in issue
What is the market cap of Inovio Pharmaceuticals?
The market capitalisation of Inovio Pharmaceuticals is USD 54,29M
What is the 1 year trading range for Inovio Pharmaceuticals share price?
Inovio Pharmaceuticals has traded in the range of US$ 1,74 to US$ 14,748 during the past year
What is the PE ratio of Inovio Pharmaceuticals?
The price to earnings ratio of Inovio Pharmaceuticals is -0,4
What is the cash to sales ratio of Inovio Pharmaceuticals?
The cash to sales ratio of Inovio Pharmaceuticals is 65,2
What is the reporting currency for Inovio Pharmaceuticals?
Inovio Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Inovio Pharmaceuticals?
The latest annual turnover of Inovio Pharmaceuticals is USD 832k
What is the latest annual profit for Inovio Pharmaceuticals?
The latest annual profit of Inovio Pharmaceuticals is USD -135,12M
What is the registered address of Inovio Pharmaceuticals?
The registered address for Inovio Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Inovio Pharmaceuticals website address?
The website address for Inovio Pharmaceuticals is www.inovio.com
Which industry sector does Inovio Pharmaceuticals operate in?
Inovio Pharmaceuticals operates in the SURGICAL,MED INSTR,APPARATUS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ASSTAsset Entities Inc
US$ 0,9747
(109,84%)
36,7M
BBGIBeasley Broadcast Group Inc
US$ 13,17
(59,25%)
24
EDRYEuroDry Ltd
US$ 18,08
(58,88%)
12
LXEOLexeo Therapeutics Inc
US$ 7,99
(57,59%)
1
HSDTHelius Medical Technologies Inc
US$ 1,17
(55,79%)
18,62M
GOEVCanoo Inc
US$ 0,46
(-65,93%)
2,04M
ELVNEnliven Therapeutics Inc
US$ 10,11
(-52,91%)
20
CUBLionheart Holdings
US$ 5,11
(-49,51%)
1
ALRSAlerus Financial Corporation
US$ 12,01
(-38,79%)
13
MDXGMiMedx Group Inc
US$ 6,01
(-34,10%)
9
CRKNCrown Electrokinetics Corporation
US$ 0,1391
(11,28%)
82,15M
ASSTAsset Entities Inc
US$ 0,9747
(109,84%)
36,7M
NIVFNewGenIvf Group Ltd
US$ 0,3631
(4,04%)
21,35M
HSDTHelius Medical Technologies Inc
US$ 1,17
(55,79%)
18,62M
CGBSCrown LNG Holdings Ltd
US$ 0,8269
(10,58%)
12,86M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
INO
Inovio Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten